Skip to content
Home/Companies/Healthcare/Nordic Biomarker

Nordic Biomarker

Healthcare·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Nordic Biomarker?

Nordic Biomarker is a Swedish Healthcare company, currently owned by Procuritas Capital Investors since 2022.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Procuritas Capital Investors
Investor
Procuritas Capital Investors
PCI VII · 2022 · Small-Mid Buyout

Key facts

HQSweden
SectorHealthcare
StatusActive

More from PCI VII

Other portfolio companies in the same fund.

Parkman
Active
Business ServicesSweden· 2025
Energima
Active
Business ServicesNorway· 2024
Precision BioLogic
Active
HealthcareCanada· 2024
PropTech
Active
Real EstateSweden· 2023
Werksta
Active
Business ServicesSweden· 2022
weselect
Active
HR TechSweden· 2022

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Nordic Biomarker?

Nordic Biomarker is currently owned by Procuritas Capital Investors, through PCI VII, since 2022.

When did Procuritas Capital Investors acquire Nordic Biomarker?

Procuritas Capital Investors acquired Nordic Biomarker in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue